Literature DB >> 32659405

Nanosuspensions of a poorly soluble investigational molecule ODM-106: Impact of milling bead diameter and stabilizer concentration.

Mayank Singhal1, Ana Baumgartner2, Elina Turunen3, Bert van Veen3, Jouni Hirvonen2, Leena Peltonen4.   

Abstract

Aqueous solubility of a drug substance is an important attribute affecting oral bioavailability. Nanonization, particle size reduction to submicron level, is an elegant approach to improve drug solubility and dissolution by increasing the surface energy, which in turn necessitates the use of stabilizers. The purpose of this study was to develop a nanosuspension of a practically water-insoluble investigational molecule by nanomilling approach using wet media milling. A variety of polymeric and surface active excipients were tested for their wettability. A combination of hydroxypropyl methylcellulose and sodium lauryl sulfate (SLS) were selected as stabilizers on the bases of compatibility studies and efficient wettability behaviour in contact angle measurements (≈80˚). A factorial design set-up was used to study the effect of milling bead diameter and stabilizer concentration on the efficiency of particle size reduction. Nanonization outcome was different when milling beads of 0.5 mm and 1 mm diameter were used at different concentrations of the stabilizers, which demonstrated the complex nature of the whole system. Storage of the nanosuspensions under different temperature conditions resulted only in minor changes of the particle size fractions.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hydrophobic drug; Nanocrystals; Nanonization; Stabilizer; Surfactant; Wet milling

Mesh:

Substances:

Year:  2020        PMID: 32659405     DOI: 10.1016/j.ijpharm.2020.119636

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  Transformation of Ritonavir Nanocrystal Suspensions into a Redispersible Drug Product via Vacuum Drum Drying.

Authors:  Barbara V Schönfeld; Ulrich Westedt; Benjamin-Luca Keller; Karl G Wagner
Journal:  AAPS PharmSciTech       Date:  2022-05-09       Impact factor: 3.246

2.  Naringenin nanocrystals for improving anti-rheumatoid arthritis activity.

Authors:  Guangshuai Zhang; Guangyuan Sun; Haishan Guan; Mo Li; Yanhua Liu; Baocheng Tian; Zhonggui He; Qiang Fu
Journal:  Asian J Pharm Sci       Date:  2021-09-16       Impact factor: 6.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.